Oversold, OCGN is gaining momentum. According to Tip Ranks, “Ocugen has inked a deal with India-based Bharat Biotech for the US rights for the company’s vaccine COVAXIN. And Bharat has now reported positive second interim analysis results from the COVAXIN Phase 3 trials. The vaccine displayed an overall efficacy rate of 78%, with 100%....

The stock market closed mostly higher on Monday and the first official trading day for May despite mixed economic news as first-quarter earnings remain broadly supportive. Specifically, news that 87% of the S&P 500 companies that had reported through last Friday have topped analysts’ expectations helped bullish sentiment. The Dow traded to a midday....

....

The stock market struggled on Friday and the last trading day of April as profit taking going into the weekend and month end weighed on sentiment. However, the four major indexes posted strong gains for the month with the S&P 500 leading the way after jumping 5.2% while the Nasdaq rose 5%. The Dow was....

Twitter’s stock was down more than 11% in after-hours trading on Thursday after the company released its first-quarter earnings, missing on user growth expectations and providing lower revenue guidance for the second quarter than expected. Here’s what Twitter reported versus Wall Street’s estimates: Earnings: 16 cents per share, adjusted, vs. 14 cents forecast by Refinitiv....

The stock market hit record levels on Thursday’s open but was somewhat choppy afterwards as Wall Street weighed a batch of better-than-expected Tech earnings and proposals from President Biden in his State of the Union address. A rise in treasury yields slowed momentum before a recovery afterwards with more key earnings updates, including Amazon.com....

Oversold, OCGN is gaining momentum. According to Tip Ranks, “Ocugen has inked a deal with India-based Bharat Biotech for the US rights for the company’s vaccine COVAXIN. And Bharat has now reported positive second interim analysis results from the COVAXIN Phase 3 trials. The vaccine displayed an overall efficacy rate of 78%, with 100%....

The stock market was choppy heading into the latest update from the Federal Reserve on Wednesday but gained momentum after the announcement of holding interest rates near-zero. The minutes were a little more upbeat than last month, noting progress on vaccinations and strong policy support are helping strengthen economic indicators, including employment. The Fed....

....

The stock market rebounded on Friday with the gains nearly giving the bulls the weekly win. However, the bears did just enough damage throughout the week to get their first overall victory in five weeks. The rally was enough to lift the small-caps to a weekly gain with the S&P 500 setting a fresh all-time....